Activated Long-Term Peripheral Blood Cultures as Preparation for Adoptive Alloreactive Cell Therapy in Cancer Patients
Explore this paper's citation graph
Summary
Successful in vitro expansion of PBMC might be helpful for gene transfer into T lymphocytes, as well as for the induction of an antitumor response, particularly for prevention and treatment of relapse of hematologic malignancies following allogeneic or autologous bone marrow transplantation.
- Type
- article
- Published
- 1997-04-01
- Cited by
- 13
- References
- 35
- OpenAlex
- https://openalex.org/W9131440
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:46358652
Keywords
Column (typography), Geometry, Computation, Computer science, Computational geometry
References
- Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer.
- Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.
- Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
- Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
- Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
- Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
- Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
- Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
- CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation.
- Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
- The glomerular permeability determined by dextran clearance using Sephadex gel filtration.
- Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
- Separation, phenotyping and limiting dilution analysis of T‐lymphocytes infiltrating human solid tumors
- Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
- PRECLINICAL STUDIES FOR ADOPTIVE IMMUNOTHERAPY IN BONE MARROW TRANSPLANTATION: GENERATION OF ANTI‐CD3 ACTIVATED CYTOTOXIC T CELLS FROM NORMAL DONORS AND AUTOLOGOUS BONE MARROW TRANSPLANT CANDIDATES
- Long-term growth of human T cell lines and clones on anti-CD3 antibody-treated tissue culture plates.
- Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes
- Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines.
- The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities.
Cited by
- Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distribution.
- Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?
- Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors
- Large-Scale Production of CD4+ T Cells from HIV-1-Infected Donors After CD3/CD28 Costimulation*
- Biotechnologische Aspekte derKultivierung humaner T‐Lymphozyten
- Ex vivo expansion of functional T lymphocytes from HIV-infected individuals.
- Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?
- Expansion and Fibronectin-Enhanced Retroviral Transduction of Primary Human T Lymphocytes for Adoptive Immunotherapy
- Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
- Bioprocess development for the cultivation of human T-lymphocytes in a clinical scale
- The Benefits of an Alloresponse: Graft-Versus-Tumor
- Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition
- Creating a Biomimetic Microenvironment for the Ex Vivo Expansion of Primary Human T Lymphocytes.